Neil F. Mc Farlane is President and CEO of KEMPHARM, INC. Currently has a direct ownership of 191,516 shares of KMPH, which is worth approximately $946,089. The most recent transaction as insider was on Feb 14, 2025, when has been sold 30,544 shares (Common Stock) at a price of $8.05 per share, resulting in proceeds of $245,879. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 192K
n/a 3M change
n/a 12M change
Total Value Held $946,089

Neil F. McFarlane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
SELL
Open market or private sale
$245,879 $8.05 p/Share
30,544 Reduced 13.75%
191,516 Common Stock
Feb 13 2025
SELL
Open market or private sale
$481,605 $7.86 p/Share
61,273 Reduced 21.63%
222,060 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
233,333 Added 45.16%
283,333 Common Stock

Also insider at

COLL
COLLEGIUM PHARMACEUTICAL, INC Healthcare
NFM

Neil F. Mc Farlane

President and CEO
Stoughton, MA

Track Institutional and Insider Activities on KMPH

Follow KEMPHARM, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KMPH shares.

Notify only if

Insider Trading

Get notified when an Kempharm, Inc insider buys or sells KMPH shares.

Notify only if

News

Receive news related to KEMPHARM, INC

Track Activities on KMPH